No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
336 |
4. Check minimum number of eventsNone |
336 |
5. Include endpointsNone |
336 |
6. Filter based on genotype QC (FinnGen only) |
326 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Leiomyosarcoma, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, wide definition for exclusion
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 326 | 222 | 104 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.05 |
| Median age at first event (years) | 60.60 | 59.30 | 63.38 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 336
- Matched controls
- 3360
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
123.8
243.3
125
16
A04AA01
ATC
ondansetron; systemic, rectal
30.9
123.5
86
37
130
Kela drug reimbursment
Malignant tumour
+∞
121.4
109
*
A03FA01
ATC
metoclopramide; systemic, rectal
11.0
108.0
165
271
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
+∞
107.2
97
*
JN4BD
NOMESCO Finland
Extensive body CT
18.3
106.9
96
72
JN4AD
NOMESCO Finland
Body CT examination
16.8
101.1
95
77
Z51.5
ICD-10 Finland
Palliative care
19.2
91.8
78
52
WX302
NOMESCO Finland
Thoracal epidural anesthesy
28.4
84.2
59
25
XX3DW
NOMESCO Finland
Time consuming IT work
15.6
83.6
80
66
TPX10
NOMESCO Finland
Implantation of vascular injection port
29.0
80.7
56
23
L03AA13
ATC
pegfilgrastim; parenteral
454.2
73.8
71
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
445.8
72.6
70
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
22.0
69.7
54
29
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
65.8
61
*
C49.23
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip leiomyosarcoma
+∞
59.1
55
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
59.1
55
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
56.9
53
*
N02AA05
ATC
oxycodone; systemic
6.2
55.5
129
306
A04AA02
ATC
granisetron; systemic, transdermal
623.4
55.2
53
*
B01AB10
ATC
tinzaparin; parenteral
8.2
55.0
86
136
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.5
54.9
67
78
L03AA02
ATC
filgrastim; parenteral
+∞
51.4
48
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
50.3
47
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.7
47.8
45
35
WF049
NOMESCO Finland
Radiotherapy of metastasis
527.4
47.5
46
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
45.9
43
*
LCD00
NOMESCO Finland
Hysterectomy
9.1
43.5
58
75
WZC00
NOMESCO Finland
Treatment plan or consultation
4.7
43.3
161
550
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
42.6
40
*
8890/3-C54.9
ICD-O-3
Leiomyosarcoma, NOS, of corpus uteri
+∞
42.6
40
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
17.4
42.3
36
23
159
Kela drug reimbursment
Pazopanib
+∞
41.5
39
*
C54.2
ICD-10 Finland
Malignant neoplasm: Myometrium
+∞
41.5
39
*
WZC30
NOMESCO Finland
Teaching
5.8
40.7
90
199
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
226.2
39.8
40
*
8890/3-C49.2
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
38.3
36
*
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
38.3
36
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
11.0
37.3
42
43
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
11.5
36.7
40
39
WW500
NOMESCO Finland
Blood transfusion
15.1
36.1
33
24
L02BG04
ATC
letrozole; oral
106.8
35.5
38
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
15.3
35.3
32
23
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
12.5
34.1
35
31
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
+∞
33.9
32
*
A04AD12
ATC
aprepitant; systemic
+∞
33.9
32
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
31.8
30
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
7.7
30.5
46
68
B01AB05
ATC
enoxaparin; parenteral
3.7
30.3
165
701
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
29.6
28
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
28.5
27
*
WF002
NOMESCO Finland
Radical radiotherapy
85.2
28.3
31
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.9
28.2
41
58
C49.43
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen leiomyosarcoma
+∞
27.5
26
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
26.4
25
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
26.4
25
*
JAH00
NOMESCO Finland
Laparotomy
10.8
25.0
28
28
D70.82
ICD-10 Finland
Drug-induced neutropenia
140.4
25.0
26
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.7
24.9
42
70
L01XE11
ATC
[U] pazopanib
+∞
24.3
23
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
23.5
118
464
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
23.2
22
*
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
246.1
22.9
23
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
67.3
22.2
25
*
115
Kela drug reimbursment
Breast cancer
+∞
22.1
21
*
C49.13
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder leiomyosarcoma
+∞
22.1
21
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
22.1
21
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
234.6
21.9
22
*
ZX120
NOMESCO Finland
Intravenous
5.4
21.3
45
93
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
21.1
20
*
343
Kela drug reimbursment
Pazopanib
+∞
21.1
20
*
WX402
NOMESCO Finland
General anaesthesia
3.6
20.9
86
296
PJA12
NOMESCO Finland
Sentinel node biopsy
223.3
20.8
21
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
20.5
196
1088
JN4CD
NOMESCO Finland
Very extensive body CT
18.8
20.4
31
18
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
8.2
20.3
28
37
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
20.0
19
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
20.0
19
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
20.0
19
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
20.0
19
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
19.9
60
166
ZZR00
NOMESCO Finland
Flap of skin
58.6
19.2
22
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
18.9
18
*
8890/3-C49.1
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
18.9
18
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
200.7
18.7
19
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
46.8
18.5
22
5
L01EX03
ATC
pazopanib; oral
+∞
17.9
17
*
C49.53
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis leiomyosarcoma
+∞
17.9
17
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
17.9
17
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
17.9
17
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.3
17.8
51
135
GD1AD
NOMESCO Finland
Thorax CT examination
5.3
17.0
36
74
ZX090
NOMESCO Finland
Other technic of radiotherapy
66.9
16.9
19
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.1
16.8
26
39
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
16.8
16
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
16.8
16
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
16.8
16
*
C49.33
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the chest leiomyosarcoma
+∞
16.8
16
*
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
3.7
16.2
58
180
A79
ICPC
Malignancy NOS
+∞
15.7
15
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
15.7
15
*
8890/3-C48.0
ICD-O-3
Leiomyosarcoma, NOS, of retroperitoneum
+∞
15.7
15
*
S18
ICPC
Laceration/cut
2.5
15.4
183
1081
B01AB04
ATC
dalteparin; parenteral
5.3
15.3
32
65
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.9
15.1
24
37
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
16.0
15.1
24
16
C49.03
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck Leiomyosarcoma
+∞
14.7
14
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
14.7
14
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
14.7
14
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
14.7
14
*
8890/3-C49.4
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
14.7
14
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.5
13.9
53
171
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
78.4
13.7
15
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
13.6
13
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
13.6
13
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
13.6
13
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
13.6
13
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
145.6
13.5
14
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
19.2
13.5
20
11
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.0
13.2
40
110
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
12.9
75
309
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.8
12.9
30
67
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
18.2
12.7
19
11
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
12.6
12
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
12.6
12
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.3
12.3
52
179
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
11.9
42
128
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
11.9
54
193
Z31.5
ICD-10 Finland
Genetic counselling
5.8
11.8
22
40
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
31.3
11.7
15
5
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
11.5
11
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
11.5
11
*
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
11.5
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.5
11
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
11.5
11
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
11.5
11
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
11.5
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
124.1
11.5
12
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.4
11.5
23
26
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
11.4
73
315
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.3
10.9
29
72
C03CA01
ATC
furosemide; systemic
2.2
10.9
134
775
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
10.7
136
794
B02AA02
ATC
tranexamic acid; systemic
2.7
10.7
68
292
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
113.4
10.5
11
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
113.4
10.5
11
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
113.4
10.5
11
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
12.6
10.5
18
15
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
10.5
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C54.12
ICD-10 Finland
Adenosquamous carcinoma of the endometrium
+∞
10.5
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
10.5
10
*
C49.63
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the torso, unspecified localization leiomyosarcoma
+∞
10.5
10
*
8890/3-C55.9
ICD-O-3
Leiomyosarcoma, NOS, of uterus, NOS
+∞
10.5
10
*
X77
ICPC
Malignant neopl genital female other
+∞
10.5
10
*
C49.83
ICD-10 Finland
Overall malignant tumor of connective tissue and other soft tissue leiomyosarcoma
+∞
10.5
10
*
C54.29
ICD-10 Finland
Unspecified uterine sarcoma
+∞
10.5
10
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
10.5
10
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.4
10.5
21
41
R50.9
ICD-10 Finland
Fever, unspecified
2.7
10.4
61
251
SPAT1255
SPAT
Intravenous administration of medicine
3.8
10.3
33
94
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
10.1
56
224
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
17.4
10.0
15
9
M05BX04
ATC
denosumab; parenteral
3.6
9.7
33
98
ZZA00
NOMESCO Finland
Split skin graft
8.8
9.7
20
24
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.5
9.6
18
18
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
7.9
9.6
21
28
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
102.8
9.5
10
*
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
1820C
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]
+∞
9.4
9
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
+∞
9.4
9
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
9.4
9
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.6
9.4
61
264
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
9.1
24
59
JFB30
NOMESCO Finland
Right hemicolectomy
37.8
9.1
11
*
XX2RW, ,
NOMESCO Finland
37.8
9.1
11
*
SPAT1153
SPAT
Removal of sutures
2.1
9.1
119
696
JAL00
NOMESCO Finland
Biopsy of peritoneum
24.8
9.0
12
5
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
51.4
8.7
10
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
10.4
8.6
16
16
HAB99
NOMESCO Finland
Other partial excision of mammary gland
28.3
8.5
11
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
20.7
8.5
12
6
L02BA01
ATC
tamoxifen; oral
92.3
8.5
9
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
92.3
8.5
9
*
KAC00
NOMESCO Finland
Nephrectomy
92.3
8.5
9
*
D25.1
ICD-10 Finland
Intramural leiomyoma of uterus
3.5
8.4
30
92
J01MA12
ATC
levofloxacin; systemic
2.3
8.4
69
333
8890/3-C49.5
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
8.4
8
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
8.4
8
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
8.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
C49.93
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue leiomyosarcoma
+∞
8.4
8
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
8.4
8
*
WZC15, ,
NOMESCO Finland
+∞
8.4
8
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
8.4
8
*
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
8.4
8
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
+∞
8.4
8
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
8.4
8
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
8.4
8
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
8.4
8
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
8.4
8
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
8.3
45
177
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.1
8.3
23
59
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.8
8.2
43
166
JAL30
NOMESCO Finland
Omentectomy
17.7
8.1
12
7
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
34.2
8.1
10
*
R4110
NOMESCO Finland
Physiotherapy
2.1
8.1
99
560
A06AH03
ATC
naloxegol; oral
22.7
8.1
11
5
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
8.8
7.9
16
19
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
4.5
7.8
19
44
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
46.1
7.7
9
*
JFB00
NOMESCO Finland
Partial resection of small intestine
18.9
7.6
11
6
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.1
7.5
21
54
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
81.8
7.4
8
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
7.1
7.4
17
25
HA1AA
NOMESCO Finland
X-ray mammography
4.3
7.4
19
46
8890/3-C64.9
ICD-O-3
Leiomyosarcoma, NOS, of kidney, NOS
+∞
7.3
7
*
C49.40
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen without histology
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
8890/3-C44.6
ICD-O-3
Leiomyosarcoma, NOS, of skin of upper limb and shoulder
+∞
7.3
7
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
8890/3-C49.6
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
7.3
7
*
8890/3-C44.7
ICD-O-3
Leiomyosarcoma, NOS, of skin of lower limb and hip
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
7.3
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
7.3
7
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
7.3
7
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
30.7
7.2
9
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
6.3
7.2
18
30
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
7.2
7.1
16
23
R4190
NOMESCO Finland
Nutritional therapy
6.1
7.0
18
31
A02BC02
ATC
pantoprazole; systemic
1.9
7.0
236
1847
JAH01
NOMESCO Finland
Laparoscopy
3.9
6.9
20
53
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.5
6.9
14
17
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
40.9
6.8
8
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
40.9
6.8
8
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
40.9
6.8
8
*
JN6AD
NOMESCO Finland
CT of torso and neck
17.1
6.8
10
6
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.0
6.7
30
106
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.7
6.7
18
33
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
8.1
6.7
14
18
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.0
6.6
91
532
D25.0
ICD-10 Finland
Submucous leiomyoma of uterus
3.7
6.5
21
60
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
71.1
6.4
7
*
TPX15
NOMESCO Finland
Removal of vascular injection port
71.1
6.4
7
*
D77
ICPC
Malignant digestive neopl other/NOS
71.1
6.4
7
*
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
11.3
6.3
11
10
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
7.3
6.3
14
20
L02BG03
ATC
anastrozole; oral
+∞
6.3
6
*
C49.1
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder
+∞
6.3
6
*
N07BC02
ATC
methadone; systemic
+∞
6.3
6
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
6.3
6
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
6.3
6
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
6.3
6
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
6.3
6
*
C48.83
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum leiomyosarcoma
+∞
6.3
6
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
6.3
6
*
XX9XW, ,
NOMESCO Finland
27.2
6.3
8
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
6.5
6.2
15
24
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
6.2
73
403
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.9
6.2
16
28
UKC02
NOMESCO Finland
Cystoscopy
2.2
6.1
52
253
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
68
131
6.25
35.27
2.2
1.4
2.40
2.60
ug/l
0.23
46
103
223
1100
4.05
33.51
3.7
2.3
—
—
—
0
0
140
557
3.59
28.08
3.5
2.0
—
—
—
0
0
206
1111
3.21
23.92
7.4
3.7
34.08
35.62
g/l
3.20
196
1025
238
1405
3.38
23.47
19.7
6.2
4.03
4.20
e9/l
0.44
214
1219
220
1277
3.09
21.61
8.2
5.9
1.20
1.22
mmol/l
1.74
184
1106
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
63
6.48
21.38
2.6
2.9
0.33
0.37
u/ml
0.32
21
40
204
1162
2.92
20.27
7.8
5.4
1.21
1.22
mmol/l
0.91
193
1030
49
126
4.38
17.79
7.6
6.3
24.60
25.74
mmol/l
1.21
49
126
203
1250
2.58
15.79
16.7
16.0
1.38
1.31
inr
0.35
61
354
271
2026
2.75
12.47
17.2
5.1
89.87
76.31
u/l
5.15
264
1849
68
278
2.81
11.84
7.2
8.4
0.54
1.91
mmol/l
2.98
50
232
104
527
2.41
11.64
5.7
2.2
2.47
2.44
mmol/l
1.86
95
458
151
899
2.23
11.54
8.9
2.1
2.36
2.35
mmol/l
0.20
142
750
48
163
3.27
11.54
1.8
1.6
—
—
—
0
0
88
418
2.50
11.31
2.0
1.8
—
—
—
0
0
66
277
2.72
10.88
7.4
8.5
15.85
11.46
kpa
5.74
61
268
240
1754
2.29
10.63
5.8
4.5
196.00
3551.56
e6/l
—
7
25
220
1555
2.20
10.56
6.3
4.3
7.01
6.71
mmol/l
0.90
214
1444
50
188
2.95
10.08
6.7
2.6
1.24
1.22
mmol/l
1.23
45
156
26
65
4.25
9.70
1.8
1.4
—
—
—
0
0
19
38
5.24
9.20
3.9
3.1
58.16
59.37
%
0.10
19
38
175
1201
1.95
8.30
6.5
5.4
23.31
27.63
%
5.31
164
1109
18
38
4.95
8.21
3.8
2.6
3.36
4.40
e9/l
0.85
18
38
63
296
2.39
8.10
1.8
1.8
—
—
—
0
0
134
847
1.97
8.03
2.8
2.1
56.05
63.49
u/l
0.52
126
773
62
293
2.37
7.86
1.8
1.8
—
—
—
0
0
57
261
2.43
7.74
6.3
3.0
—
—
—
0
0
129
816
1.94
7.63
6.7
2.6
40.34
31.18
u/l
0.83
122
775
19
32
6.23
7.49
1.2
1.2
—
—
—
0
0
171
1192
1.88
7.48
5.9
5.1
60.41
57.57
%
1.99
160
1101
56
259
2.39
7.43
3.3
2.0
13.82
5.88
umol/l
1.00
51
222
11
7
16.18
7.27
1.8
1.7
—
—
—
0
0
11
7
16.18
7.27
2.2
1.3
21.92
13.37
ug/l
—
11
7
114
704
1.94
7.16
3.3
2.9
0.57
0.44
e6/l
0.27
90
528
16
25
6.66
6.72
1.5
1.6
3.30
150.96
u/ml
0.48
16
25
79
441
2.03
6.56
3.0
2.5
1.05
1.46
e6/l
0.82
50
238
73
402
2.04
6.27
3.4
2.7
3.89
3.38
e6/l
0.16
43
199
16
43
3.86
5.43
1.5
1.1
—
—
—
0
0
61
334
2.01
5.28
2.8
2.4
21.43
23.66
%
0.70
53
284
34
153
2.36
4.78
1.4
1.5
—
—
—
0
0
32
142
2.39
4.64
2.1
1.7
—
—
—
0
0
17
54
3.26
4.55
1.6
1.2
—
—
—
0
0
11
20
5.65
4.32
1.6
1.3
—
—
—
0
0
8
10
8.16
4.08
1.1
1.4
—
—
—
0
0
16
53
3.12
4.02
4.3
3.1
4.67
5.20
kpa
1.81
16
53
16
53
3.12
4.02
1.4
1.4
—
—
—
0
0
103
715
1.64
3.98
4.7
3.9
0.00
0.00
estimate
-0.00
32
222
121
874
1.60
3.97
2.8
3.0
2248.23
1401.59
ng/l
1.03
109
736
8
11
7.42
3.88
3.1
1.7
5.06
3.29
nmol/l
—
8
11
17
60
2.93
3.85
1.6
1.2
—
—
—
0
0
13
33
4.06
3.84
1.5
1.2
—
—
—
0
0
13
34
3.93
3.73
1.7
1.2
—
—
—
0
0
8
12
6.80
3.69
1.5
1.2
—
—
—
0
0
46
259
1.90
3.66
3.3
2.9
2.29
2.42
mmol/l
0.08
37
217
11
25
4.51
3.65
1.6
1.2
—
—
—
0
0
12
30
4.11
3.63
1.6
1.2
—
—
—
0
0
12
30
4.11
3.63
1.4
1.1
—
—
—
0
0
168
1329
1.53
3.60
4.1
3.7
0.00
0.00
estimate
0.50
36
239
7
9
7.91
3.57
2.7
2.1
—
—
—
0
0
24
486
0.45
3.54
1.3
1.3
24.52
14.63
u/ml
0.22
13
183
13
37
3.61
3.44
1.5
1.2
—
—
—
0
0
169
1350
1.51
3.39
4.2
3.7
0.00
0.01
estimate
0.50
34
222
167
1331
1.51
3.39
5.3
5.2
0.00
0.00
estimate
-0.00
35
218
7
10
7.12
3.38
1.6
1.2
—
—
—
0
0
7
10
7.12
3.38
1.6
1.2
—
—
—
0
0
40
222
1.91
3.33
2.7
2.0
45.50
35.51
u/l
0.32
34
183
296
2701
1.81
3.12
29.1
12.5
29.81
21.79
mg/l
3.65
275
2051
22
101
2.26
3.00
2.5
1.7
—
—
—
0
0
7
13
5.47
2.88
1.3
1.2
—
—
—
0
0
6
9
6.76
2.88
1.0
1.1
—
0.97
—
0
9
5
6
8.43
2.76
4.0
1.0
70.00
82.17
nmol/l
—
5
6
91
664
1.51
2.72
1.9
2.2
2.92
3.08
mg/l
0.28
78
552
141
1128
1.43
2.61
3.9
3.8
27.03
70.68
ng/l
0.82
112
815
74
524
1.53
2.53
3.9
4.3
21.35
244.31
ng/l
1.93
63
420
13
51
2.61
2.47
1.7
2.2
1.71
1.69
mg/l
0.03
13
46
262
2828
0.67
2.35
4.7
5.2
2.65
2.75
mmol/l
1.08
235
2584
31
508
0.57
2.34
1.3
1.3
16.49
37.49
iu/ml
—
10
160
14
59
2.43
2.32
1.3
1.7
—
—
—
0
0
52
749
0.64
2.32
1.4
1.6
1.38
1.34
mmol/l
0.21
39
627
197
1707
1.37
2.13
4.2
2.9
65.31
45.91
u/l
2.01
187
1568
38
240
1.66
2.10
2.2
3.7
165.13
236.67
ng/l
0.76
31
220
34
210
1.69
2.04
4.0
1.8
60.18
64.30
ml/min/173m2
0.26
17
70
255
2748
0.70
1.99
4.1
4.7
1.46
1.53
mmol/l
1.80
227
2511
258
2774
0.70
1.97
4.1
4.7
4.52
4.70
mmol/l
1.98
234
2545
7
22
3.23
1.89
1.1
1.1
—
—
—
0
0
8
29
2.80
1.80
1.3
1.1
—
—
—
0
0
18
95
1.95
1.79
2.5
1.6
—
—
—
0
0
126
1043
1.33
1.74
4.8
3.9
—
—
—
0
0
8
30
2.71
1.73
1.3
1.1
—
—
—
0
0
8
30
2.71
1.73
1.3
1.1
—
—
—
0
0
7
24
2.96
1.73
1.0
1.1
—
—
—
0
0
15
75
2.05
1.72
2.1
3.7
—
—
—
0
0
14
69
2.07
1.67
1.3
1.2
—
—
—
0
0
8
31
2.62
1.67
1.3
1.1
—
—
—
0
0
8
31
2.62
1.67
1.3
1.1
—
—
—
0
0
8
31
2.62
1.67
1.1
1.1
—
—
—
0
0
277
2581
1.42
1.65
30.4
11.2
77.53
77.14
ml/min/173m2
0.11
260
2065
0
45
0.00
1.51
0.0
1.4
—
—
—
0
0
12
59
2.07
1.45
1.2
1.2
—
—
—
0
0
6
22
2.76
1.44
2.3
1.2
—
—
—
0
0
6
23
2.64
1.37
2.0
2.1
—
—
—
0
0
5
17
2.97
1.36
1.2
1.6
—
—
—
0
0
5
17
2.97
1.36
1.2
1.6
—
—
—
0
0
74
588
1.33
1.33
1.9
1.6
1.92
0.99
mg/l
1.63
58
452
5
19
2.66
1.22
1.2
1.8
—
—
—
0
0
38
277
1.42
1.16
1.7
2.5
10.69
7.25
ug/l
0.18
29
238
249
2633
0.79
1.07
6.3
5.9
42.29
40.04
mmol/mol
2.18
223
2434
7
34
2.08
1.03
1.3
1.0
—
—
—
0
0
13
212
0.60
1.02
2.0
1.8
—
—
—
0
0
5
23
2.19
0.98
2.2
1.9
—
—
—
0
0
10
55
1.84
0.93
1.6
1.4
—
—
—
0
0
10
55
1.84
0.93
1.6
1.4
—
—
—
0
0
6
28
2.16
0.92
1.2
1.2
—
—
—
0
0
252
2641
0.82
0.84
3.9
4.2
1.33
1.27
mmol/l
0.73
222
2393
73
617
1.23
0.82
1.7
1.7
494.92
459.05
pmol/l
0.24
52
495
19
131
1.48
0.80
3.0
2.0
0.59
0.67
%
0.59
19
131
0
24
0.00
0.79
0.0
1.0
—
606.33
—
0
15
0
24
0.00
0.79
0.0
1.0
—
39.20
—
0
15
48
388
1.28
0.79
6.5
6.9
—
—
—
0
0
6
34
1.78
0.76
1.0
1.4
—
—
—
0
0
7
38
1.86
0.74
1.3
1.4
—
—
—
0
0
19
134
1.44
0.73
3.0
2.0
1.23
1.16
%
0.15
19
134
5
25
2.01
0.73
1.2
1.2
—
—
—
0
0
7
39
1.81
0.73
1.6
1.2
—
—
—
0
0
14
204
0.67
0.71
1.6
1.9
—
—
—
0
0
16
110
1.48
0.69
4.6
4.3
24.14
25.06
mmol/l
0.45
16
104
15
102
1.49
0.68
4.9
2.2
512.40
712.62
ug/l
0.19
15
96
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
5
27
1.86
0.68
1.2
1.1
—
—
—
0
0
265
2749
0.83
0.68
4.5
4.7
6.14
5.96
mmol/l
0.90
238
2490
6
105
0.56
0.62
1.0
2.1
30.50
41.59
u/l
—
6
93
105
1163
0.86
0.62
2.4
2.2
74.83
79.38
nmol/l
0.99
92
1014
123
1119
1.16
0.61
2.6
2.7
186.03
107.27
ug/l
2.43
113
1016
51
600
0.82
0.60
1.9
1.7
1595.40
1203.66
nmol/l
1.55
35
446
0
20
0.00
0.60
0.0
2.4
—
13.66
—
0
20
229
2180
1.16
0.60
4.8
4.0
14.93
14.87
pmol/l
0.15
212
1958
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
101
909
1.16
0.58
3.6
3.6
5.97
8.03
mg/mmol
0.42
65
552
13
182
0.70
0.55
1.5
1.8
—
—
—
0
0
79
700
1.17
0.55
1.4
1.5
22.73
21.27
nmol/l
0.30
65
597
6
96
0.62
0.53
1.5
1.5
1.18
1.15
g/l
—
6
91
6
98
0.61
0.53
2.0
1.8
—
—
—
0
0
299
2923
1.21
0.47
20.6
8.8
26.94
24.67
u/l
1.79
294
2785
5
81
0.61
0.46
2.2
1.4
—
—
—
0
0
5
83
0.60
0.46
4.0
1.3
0.24
0.06
g/l
—
5
77
11
77
1.44
0.46
1.4
1.9
—
—
—
0
0
5
85
0.58
0.46
2.0
1.4
—
—
—
0
0
13
95
1.38
0.44
1.1
1.2
—
—
—
0
0
13
95
1.38
0.44
1.1
1.2
—
—
—
0
0
12
87
1.39
0.43
1.2
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
163.26
—
0
16
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
8
61
1.32
0.40
1.4
1.8
—
—
—
0
0
78
711
1.13
0.38
2.9
2.2
332.91
10083.59
umol/l
4.25
68
617
216
2080
1.11
0.37
3.7
4.1
17.48
12.31
mm/h
2.72
190
1885
5
76
0.65
0.36
4.0
1.3
0.00
0.00
g/l
—
5
71
6
42
1.44
0.35
1.5
1.1
—
—
—
0
0
6
42
1.44
0.35
1.5
1.1
—
—
—
0
0
6
43
1.40
0.35
2.5
2.1
103.00
105.42
mmol/l
—
6
43
56
505
1.13
0.33
5.7
3.8
18.94
25.04
%
3.24
32
238
33
376
0.86
0.30
4.1
4.8
31.54
33.07
%
0.37
24
241
8
108
0.73
0.29
2.9
1.3
—
—
—
0
0
9
77
1.17
0.24
5.0
1.3
—
1.18
—
0
8
45
409
1.12
0.24
1.3
1.4
—
—
—
0
0
40
363
1.12
0.22
3.5
2.7
0.71
0.73
ug/l
0.11
31
236
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
305
3017
1.12
0.20
43.6
18.5
37.89
40.13
%
9.23
298
2800
37
404
0.91
0.19
1.4
1.4
—
—
—
0
0
7
61
1.15
0.17
1.0
1.2
51.87
27.99
iu/l
—
7
51
10
84
1.20
0.14
1.7
1.6
—
—
—
0
0
16
142
1.13
0.13
3.6
3.3
4.24
4.53
pmol/l
0.84
16
122
14
126
1.12
0.09
1.1
1.0
—
—
—
0
0
5
61
0.82
0.08
1.0
1.1
—
13.10
—
0
8
5
60
0.83
0.08
1.4
1.3
—
—
—
0
0
6
75
0.80
0.07
2.0
1.5
—
—
—
0
0
15
138
1.09
0.06
1.1
1.3
—
—
—
0
0
118
1190
0.99
0.02
1.8
2.0
90.13
96.99
pmol/l
0.84
64
576
152
1530
0.99
0.02
2.5
2.7
—
—
—
0
0
56
568
0.98
0.01
1.2
1.3
0.93
1.53
u/ml
0.77
16
158
259
2582
1.01
0.01
5.5
4.9
2.05
2.39
mu/l
0.32
237
2334
7
78
0.90
0.00
1.0
1.3
540.29
483.97
mg/l
—
7
70
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
-0.00
1.0
1.2
4.54
3.88
mmol/l
—
7
64
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
66
0.91
-0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
58
0.86
-0.00
1.8
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
7.48
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
51.66
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_LEIOMYOSARCOMA_WIDE – Leiomyosarcoma, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).